CD8A and Arthritis: Our results indicated that TSA treatment altered the CD8α+ conventional dendritic cell phenotype to that of the tolerogenic CD8α+ conventional dendritic cells and inhibited Th17 cell differentiation, leading to the suppression of arthritis in SKG mice, in which Th17 cells are critically involved [26].